CCL2 and Alzheimer disease: Single-cell RNA-sequencing in PN and AD reveals fibroblasts in AD lesions expressing CCL2, CCL19, and CCL11, which drive immune cell recruitment and inflammation via the IKKβ/NF-κB pathway, worsening AD pathology (31).